BACKGROUND: The interpretation of the increase in stride-to-stride variability of stride time (STV) regarding the evolution of cognitive deficits across the dementia spectrum is matter of debate. OBJECTIVE: The aim of this study was to compare STV at usual and fast-pace walking speeds of MCI patients with that of cognitively healthy individuals (CHI) and Alzheimer's disease (AD) patients with mild dementia, while considering the effects of potential confounders. METHODS: STV while walking at usual and fast-pace walking speeds was recorded with the GAITRite® system from 116 older adults (mean age 75.6±6.5 years; 55.2% female) divided into 3 groups according to their cognitive status (44 CHI, 39 MCI patients and 33 AD patients with mild dementia). RESULTS: The full adjusted multiple linear regression models showed that high STV was associated with slow gait speed at usual-pace walking speed (P=0.002) and with the MCI status at fast-pace walking speed (P=0.015). CONCLUSIONS: High STV at fast-pace walking speed was a specific gait disturbance of MCI patients in the sample of studied participants, and thus could be used in the future as a specific biomarker of MCI patients.
BACKGROUND: The interpretation of the increase in stride-to-stride variability of stride time (STV) regarding the evolution of cognitive deficits across the dementia spectrum is matter of debate. OBJECTIVE: The aim of this study was to compare STV at usual and fast-pace walking speeds of MCI patients with that of cognitively healthy individuals (CHI) and Alzheimer's disease (AD) patients with mild dementia, while considering the effects of potential confounders. METHODS:STV while walking at usual and fast-pace walking speeds was recorded with the GAITRite® system from 116 older adults (mean age 75.6±6.5 years; 55.2% female) divided into 3 groups according to their cognitive status (44 CHI, 39 MCI patients and 33 ADpatients with mild dementia). RESULTS: The full adjusted multiple linear regression models showed that high STV was associated with slow gait speed at usual-pace walking speed (P=0.002) and with the MCI status at fast-pace walking speed (P=0.015). CONCLUSIONS: High STV at fast-pace walking speed was a specific gait disturbance of MCI patients in the sample of studied participants, and thus could be used in the future as a specific biomarker of MCI patients.
Authors: K Pérès; V Chrysostome; C Fabrigoule; J M Orgogozo; J F Dartigues; P Barberger-Gateau Journal: Neurology Date: 2006-08-08 Impact factor: 9.910
Authors: A Kluger; J G Gianutsos; J Golomb; S H Ferris; A E George; E Franssen; B Reisberg Journal: J Gerontol B Psychol Sci Soc Sci Date: 1997-01 Impact factor: 4.077
Authors: Michael Schwenk; Marwan Sabbagh; Ivy Lin; Pharah Morgan; Gurtej S Grewal; Jane Mohler; David W Coon; Bijan Najafi Journal: J Rehabil Res Dev Date: 2016
Authors: Manuel M Montero-Odasso; Yanina Sarquis-Adamson; Mark Speechley; Michael J Borrie; Vladimir C Hachinski; Jennie Wells; Patricia M Riccio; Marcelo Schapira; Ervin Sejdic; Richard M Camicioli; Robert Bartha; William E McIlroy; Susan Muir-Hunter Journal: JAMA Neurol Date: 2017-07-01 Impact factor: 18.302
Authors: Rodolfo Savica; Alexandra M V Wennberg; Clinton Hagen; Kelly Edwards; Rosebud O Roberts; John H Hollman; David S Knopman; Bradley F Boeve; Mary M Machulda; Ronald C Petersen; Michelle M Mielke Journal: J Alzheimers Dis Date: 2017 Impact factor: 4.472